))
E168 - New and emerging drug therapies for Alzheimer disease
Manage episode 430192504 series 3557583
Content provided by Australian Prescriber. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Prescriber or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
David Liew speaks with geriatrician and dementia specialist Louise Waite about her article on new and emerging therapies for Alzheimer disease. Louise explains key biomarkers for Alzheimer disease, and the potentially disease-modifying monoclonal antibody therapies that have been approved by the FDA and are now being considered by the TGA in Australia. Read the full article by Louise in Australian Prescriber.
171 episodes
Share
